011HO15284 ALTASTEALTH

Print/PDF
Registration Name SHILOH-USA STEALTH-ET
Registration Number HO840003201522153
Primary NAAB Code 011HO15284
Secondary Code(s) 593HO15284, 611HO15284, 581HO15284, 511HO15284, 122HO15284
Status Inactive
Controller Name Alta Genetics (11)
Date of Birth 5/15/2019
aAa 342
DMS 345,135
GFI 11.9%
Genetic Codes * TL TR TD TC TP TY TV TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5C, HH6T
Sire PEAK ALTAHOTJOB-ET
MGS BLUMENFELD JEDI RESOLVE-ET
Beta Casein A2A2
Kappa Casein AA
Beta Lactoglobulin AB
INDEXES
NM$ 526, 93% R CM$ 519
NM Percentile 56% FM$ 544
GTPI 2984 GM$ 454
PRODUCTION TRAITS
3684 Dtrs 536 herds 40 % US 99% R
Milk 1656 Fat, % 48 , -0.07%
SCS 2.95, 98% R Protein, % 44 , -0.04%
Feed Saved -83 , 72% R Milking Speed 7.52 , 95% R
Health & Fertility
Productive Life 2.6      96% R Mastitis 0.6      91% R
Heifer Livability 0.3       81% R Metritis 0.8      86% R
Livability 1.8      84% R D. Abom 0.1      94% R
DPR -1.6      95% R Ketosis 2.5      85% R
HCR -1.3      94% R R. Placenta 0.6      88% R
CCR -1.7      96% R Milk Fever 0.0      75% R
SCR -        -
Calving Traits
Sire CE 1.0      97% R 4655 Obs
Daughter CE 1.2      93% R 813 Obs, 1564 Dtrs
Sire SB 3.1      95% R 6525 Obs
Daughter SB 2.9      93% R 710 Obs, Dtrs
Gestation Length -1.4      99% R 112 Obs, 2012 Dtrs
Early First Calving 1.3      93% R 105 Obs, 1285 Dtrs

CDCB December 2025; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 12/2025
972 Dtrs 195 herds 96% R
PTA Type 0.58 UDC 0.54
FLC 0.36 BWC 0.74
Linear Traits
Stature -0.39
Short
Strength 0.49
Weak
Body Depth -0.26
Shallow
Dairy Form -1.17
Closed
Rump Angle -1.52
Flat
Thurl Width -0.31
Narrow
Rear Legs-Side View -1.28
Straight
Rear Legs-Rear View 0.41
Straight
Foot Angle 0.92
Steep
Feet & Legs Score 0.21
High
F.U. Attachment 1.19
Strong
Rear Udder Height 0.58
High
Rear Udder Width -0.06
Narrow
Udder Cleft 0.42
Strong
Udder Depth 0.52
Shallow
Front Teat Placement -0.45
Wide
Rear Teat Placement -0.14
Wide
Teat Length 0.77
Long
-2
0
2

CDCB December 2025; Base of Evaluation: HO